Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Genital warts refer to sexually transmitted infection that are usually caused due to Human Papilloma Virus (HPV).  HPV is also known to cause some types of cancer as well. However, the type of HPV that causes genital warts does not usually cause cancer. Moreover, sexually transmitted infections or STIs are infections that spread through vaginal, oral, or anal transmissions or through close sexual contact. However, many people infected with HPV never even develop genital warts. If warts do develop, they usually appear within few months of infection. But sometimes, the warts may appear years later.

Increasing prevalence of (HPV) infection, which is the reason for the development of genital warts, is expected to drive the growth of the global genital warts treatment market over the forecast period.

According to the World Health Organization (WHO): 2019, more than 1 million sexually transmitted infections (STIs) are acquired every day worldwide and more than 290 million women have a human papillomavirus (HPV) infection

The global genital warts treatment market is estimated to be valued at US$ 1,628.9 million in 2021 and is expected to exhibit a CAGR of 4.7% over the forecast period (2021-2028).

Figure 1. Global Genital Warts Treatment Market Share (%) in Terms of Value, By Region, 2021

Genital Warts Treatment  | Coherent Market Insights

Market players are indulged in launching new treatment platforms that are expected to increase the growth of the global genital warts treatment market over the forecast period.

For instance, in 2019, GenieMD, a global provider of telemedicine services, launched their telemedicine app iVisit that would allow patients to be diagnosed and treated for genital warts via virtual visit with the physician.

For instance, in August 2018, Oceanside Pharmaceuticals, a company which provides pharmaceutical services, launched an authorized generic version of Bausch Health’s Zyclara (imiquimod) 3.75% cream pump. Zyclara (imiquimod) 3.75% is indicated for the topical treatment of external genital and perianal warts/condyloma acuminata (EGW) in patients of age 12 years or older.

request-sample

Genital Warts Treatment Market Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2021: US$ 1,628.9 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2021 to 2028
Forecast Period 2021 to 2028 CAGR: 4.7% 2028 Value Projection: US$ 2,253.6 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Drug Type: Imiquimod, Podophyllin and Podofilox, Trichloroacetic Acid, Sinecatechins, Others
  • By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Companies covered:

Sanofi S.A., AbbVie Inc., Perrigo Company PLC, 3M, Lee's Pharmaceutical Holdings Ltd, Cassiopea, Glenmark Pharmaceuticals, Bausch Health, and Novartis International AG

Growth Drivers:
  • Increasing Research and Development Activities
  • Increasing Prevalence of Sexually Transmitted Diseases (STDs) and Human Papilloma Virus (HPV) infection
Restraints & Challenges:
  • Low Diagnostic Rate Due to Lack of Awareness

Figure 2. Global Genital Warts Treatment Market Share (%), by Drug Type, 2021

Genital Warts Treatment  | Coherent Market Insights

Increasing research and development in order to develop treatment for genital warts is expected to increase the growth of the global genital warts treatment market over the forecast period.

For instance, University of Pretoria, South Africa, in collaboration with University of Stellenbosch, South Africa, are currently conducting clinical trials in order to study the effectiveness of human papilloma virus (HPV) vaccine against the occurrence of genital warts. The study was initiated in the year 2018 and is expected to be completed by 2023. Currently, the study is in the Phase III clinical trial.

Global Genital Warts Treatment Market Restraint

Even though the prevalence of warts is high among the global population, its diagnosis rate is still low. The low diagnostic rate of genital warts is due to the lack of awareness about the infection, which may hamper the genital warts treatment market growth. For instance, according to the Health Protection report in 2018, the rate of genital warts’ diagnosis in England among girls aged 15 to 17 years, who were attending sexual health services, decreased by 92%, as compared to that in 2014. Moreover, existing treatment procedures are often painful or invasive, and can have undesirable outcomes such as scarring or dyspigmentation that often requires repeat visits. This results in decrease in the diagnostic rate, which in turn, is likely to restrain the genital warts therapeutics market.

Furthermore, there are no specific treatments available for genital warts. The most commonly used treatments are cauterization and freezing. On the other hand, the topical skin medications that are usually prescribed for the treatment of warts are commonly prescribed for skin conditions and skin cancers as well.

According to the National Center for Biotechnology Information (NCBI) report in 2018, in most of the cases, the immune system clears the warts within a few months. But even if the warts go away, the HPV might still be active in the body. So the warts can come back after few months or years.

Key Players

Major players operating in the global genital warts treatment market include Sanofi S.A., AbbVie Inc., Perrigo Company PLC, 3M, Lee's Pharmaceutical Holdings Ltd, Cassiopea, Glenmark Pharmaceuticals, Bausch Health, and Novartis International AG

Genital warts are a common sexually transmitted infection (STI) that is passed on by vaginal and anal intercourse, sharing sex toys, and rarely, by oral sex. There are various treatments that are available for the treatment of genital warts, which include cream or liquid ointments, surgery for removing warts, etc.

Market players are focusing on research activities for the development of treatment for genital warts. This is expected to aid in the growth of the global genital warts treatment market over the forecast period.

For instance, in November 2020, Verrica Pharmaceuticals Inc., a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, announced positive results for its Phase II CARE-1 clinical study of VP-102, a novel topical therapy containing a solution of 0.7% (w/v) cantharidin in a proprietary single-use applicator, developed for the treatment of external genital warts (EGW).

VP-102 achieved positive results on both the primary endpoint of complete clearance of all treatable EGW.

Market Dynamics

Market players and research institutes are indulged in conducting research and development, in order to develop treatment for genital warts. This is expected to increase the growth of the global genital warts treatment market over the forecast period.

For instance, in July 2018, Cassiopea SpA, a specialty pharmaceutical company, announced the availability of proof of concept for its Phase II clinical trial of ‘CB-06-02’, which is a topical 15% immune modulator tellurium-based gel designed for the treatment of genital warts at an extreme level. The proof of concept indicated the complete clearance or statistically significant reduction of genital warts in women. The trial is currently undergoing with various other endpoints.

Key features of the study:

  • This report provides in-depth analysis of the global genital warts treatment market, provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global genital warts treatment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Sanofi S.A., AbbVie Inc., Perrigo Company PLC, 3M, Lee's Pharmaceutical Holdings Ltd, Cassiopea, Glenmark Pharmaceuticals, Bausch Health, and Novartis International AG
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global genital warts treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global genital warts treatment market

Detailed Segmentation:

  • Global Genital Warts Treatment Market, By Drug Type:
    • Imiquimod
    • Podophyllin and Podofilox
    • Trichloroacetic Acid
    • Sinecatechins
    • Others
  • Global Genital Warts Treatment Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Genital Warts Treatment Market, By Region:
    • North America
      • By Drug Type
        • Imiquimod
        • Podophyllin and Podofilox
        • Trichloroacetic Acid
        • Sinecatechins
        • Others
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Drug Type
        • Imiquimod
        • Podophyllin and Podofilox
        • Trichloroacetic Acid
        • Sinecatechins
        • Others
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Drug Type
        • Imiquimod
        • Podophyllin and Podofilox
        • Trichloroacetic Acid
        • Sinecatechins
        • Others
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Drug Type
        • Imiquimod
        • Podophyllin and Podofilox
        • Trichloroacetic Acid
        • Sinecatechins
        • Others
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Drug Type
        • Imiquimod
        • Podophyllin and Podofilox
        • Trichloroacetic Acid
        • Sinecatechins
        • Others
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Drug Type
        • Imiquimod
        • Podophyllin and Podofilox
        • Trichloroacetic Acid
        • Sinecatechins
        • Others
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country/Region
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Sanofi S.A.*
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • AbbVie Inc.
    • Perrigo Company PLC
    • 3M
    • Lee's Pharmaceutical Holdings Ltd
    • Cassiopea
    • Glenmark Pharmaceuticals
    • Bausch Health
    • Novartis International AG

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Drug Type
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Drivers
    • Restraints
    • Opportunity
    • Impact Analysis
    • Epidemiology
    • Mergers and Acquisitions
    • Key Developments
    • Regulatory Scenario
    • PEST Analysis
    • Reimbursement Scenario
    • Brand Analysis
    • Pipeline Analysis
    • Therapeutics : Overview
    • Algorithm For Treatment Selection In Patients With Genital Warts
  4. Global Genital Warts Treatment Market – Impact of Coronavirus (Covid-19) Pandemic
    • COVID-19 Epidemiology
    • Supply and Demand Analysis
  5. Global Genital Warts Treatment Market, By Drug Type, 2021 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Imiquimod
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
    • Podophyllin and Podofilox
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
    • Trichloroacetic Acid
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
    • Anti-depressants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
    • Sinecatechins
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
  6. Global Genital Warts Treatment Market, By Distribution Channel, 2021 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
  7. Global Genital Warts Treatment Market, By Region, 2021 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2028
    • North America
      • Market Size and Forecast, By Drug Type, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 – 2028, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Drug Type, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 – 2028, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Drug Type, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 – 2028, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Drug Type, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 – 2028, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Drug Type, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 – 2028, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Region/Country, 2021 – 2028, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  8. Competitive Landscape
    • Competitive Snapshot
      • Sanofi S.A.*
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • AbbVie Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Perrigo Company PLC
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • 3M
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Lee's Pharmaceutical Holdings Ltd
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Cassiopea
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Glenmark Pharmaceuticals
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Bausch Health
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Novartis International AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 26 market data tables and 28 figures on "Genital Warts Treatment Market” - Global forecast to 2028

FAQgrowicon

Frequently Asked Questions

The market size is estimated to be valued at US$ 1,628.9 million in 2021 and is expected to exhibit a CAGR of 4.7% between 2021 and 2028.
Increasing research and development activities and increasing prevalence of sexually transmitted diseases (STDS) & human papilloma virus (HPV) infection are expected to drive the market growth over the forecast period.
Imiquimod drug type segment is expected to hold the major market share, owing to increasing product approvals and launches during the forecast period.
North America holds the largest market share in the market.
Major factor hampering growth of the market includes the low diagnostic rate of genital rates due to lack of awareness.
Major players operating in the market include Sanofi S.A., AbbVie Inc., Perrigo Company PLC, 3M, Lee's Pharmaceutical Holdings Ltd, Cassiopea, Glenmark Pharmaceuticals, Bausch Health, and Novartis International AG
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner